Effect of acetylsalicylic acid and selective arginase II inhibitor KUD 975 on platelet aggregation ability (A) and platelet aggregation rate (B) when inducing by ADP; on platelet aggregation ability (C) and platelet aggregation rate (D) when inducing by collagen; on platelet aggregation ability (E) and platelet aggregation rate (F) when inducing by arachidonic acid. Note: * – p<0.05 in comparison with intact pregnant females; y – p<0.05 in comparison with the L-NAME group; ADP – Adenosine diphosphate; ASA – acetylsalicylic acid.

 
 
  Part of: Gureeva AV, Severinova OV, Gureev VV, Kochkarova IS, Avdeyeva EV (2022) Study of the effect of acetylsalicylic acid and a selective arginase II inhibitor KUD 975 on the correction of hemostatic disorders in experimental preeclampsia. Research Results in Pharmacology 8(3): 1-8. https://doi.org/10.3897/rrpharmacology.8.87539